FDA — authorised 2 November 2010
- Application: NDA022450
- Marketing authorisation holder: MALLINCKRODT HOSP
- Local brand name: OFIRMEV
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 Intravenous acetominophen in United States
FDA authorised Intravenous acetominophen on 2 November 2010
Marketing authorisations
FDA
- Status: approved
Intravenous acetominophen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Intravenous acetominophen approved in United States?
Yes. FDA authorised it on 2 November 2010; FDA has authorised it.
Who is the marketing authorisation holder for Intravenous acetominophen in United States?
MALLINCKRODT HOSP holds the US marketing authorisation.